Biggest News Aggregation in the World
📰 Membrane Type News

Page 5 - Membrane Type News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Membrane Type. Real-time updates on events, politics, business and more.

Bicycle Therapeutics plc (NASDAQ:BCYC) Receives Average Recommendation of "Buy" from Analysts

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) have been assigned an average rating of “Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month price […]
Piper Sandler Needham Company Eventide Asset Management Tybourne Capital Management Hk Ltd Cantor Fitzgerald Loomis Sayles Co

Bicycle Therapeutics plc (NASDAQ:BCYC) Expected to Post Quarterly Sales of $3.70 Million

Equities research analysts expect Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) to post $3.70 million in sales for the current quarter, according to Zacks. Eight analysts have provided estimates for Bicycle Therapeutics’ earnings, with the highest sales estimate coming in at $4.18 million and the lowest estimate coming in at $2.00 million. Bicycle Therapeutics posted […]
United States Piper Sandler Morgan Stanley Northern Trust Corp Zacks Investment Research America Corp

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Bicycle Therapeutics plc (NASDAQ:BCYC) Given Average Recommendation of "Buy" by Brokerages

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) have been given an average recommendation of “Buy” by the thirteen ratings firms that are currently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1 year […]
Morgan Stanley Frazier Life Sciences Management Cantor Fitzgerald Zacks Investment Research Loomis Sayles Co Victory Capital Management Inc

Bicycle Therapeutics (NASDAQ:BCYC) Upgraded to "Hold" at Zacks Investment Research

Bicycle Therapeutics (NASDAQ:BCYC – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Monday, Zacks.com reports. According to Zacks, “Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by […]
United Kingdom United States Morgan Stanley Zacks Investment Research America Corp Truist Financial Corp

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science